CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 82 filers reported holding CYCLERION THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $412,870 | -35.5% | 371,955 | 0.0% | 0.03% | -22.0% |
| Q4 2021 | $639,763 | -44.0% | 371,955 | 0.0% | 0.04% | -48.1% |
| Q3 2021 | $1,141,902 | -22.0% | 371,955 | +50.2% | 0.08% | -60.7% |
| Q2 2020 | $1,463,688 | +63.8% | 247,663 | -26.5% | 0.20% | -9.5% |
| Q1 2020 | $893,434 | +312.3% | 337,145 | +1681.5% | 0.22% | +263.9% |
| Q2 2019 | $216,691 | – | 18,925 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MFN Partners Management, LP | 1,487,874 | $17,036,000 | 2.70% |
| BRIDGER MANAGEMENT, LLC | 1,032,633 | $11,824,000 | 0.93% |
| EcoR1 Capital, LLC | 776,206 | $8,888,000 | 0.90% |
| Camber Capital Management LP | 1,561,915 | $17,884,000 | 0.83% |
| CVI Holdings, LLC | 157,114 | $1,798,000 | 0.70% |
| Artal Group S.A. | 1,361,584 | $15,590,000 | 0.63% |
| Slate Path Capital LP | 714,018 | $8,176,000 | 0.37% |
| Sarissa Capital Management LP | 250,000 | $2,862,000 | 0.36% |
| AWH Capital, L.P. | 10,107 | $116,000 | 0.17% |
| Broderick Brian C | 32,919 | $377,000 | 0.13% |